Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies

Background The recommended dose of rasburicase is quite expensive, thus limiting its use. Whether a lower dose of rasburicase would be equally effective for critically ill children, who often have more complicated situations and a higher risk of hospital death, is still unknown. Objective To explore...

Full description

Saved in:
Bibliographic Details
Published in:Int J Clin Pharm
Main Authors: Pei, Yuxin, Li, Yu, Liang, Yujian, Xu, Lingling, Huang, Xueqiong, Li, Yijuan, Tang, Wen, Jiang, Xiaoyun
Format: Artigo
Language:Inglês
Published: Springer International Publishing 2020
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7603475/
https://ncbi.nlm.nih.gov/pubmed/32974856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11096-020-01144-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items